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Project  Description
• Tear sampling is non-invasive and used as a guide in understanding 
pathologies, including ocular and systemic inflammatory conditions. 
Tear biosamples are localized to the eye, central nervous system 
(CNS), and the brain.
• Tear biomarkers are found to be altered in various conditions, 
including inflammatory diseases, ocular diseases, metabolic disease 
and allergies (Hagan et al., 2016).
• Tear biomarkers may reflect conditions affecting the CNS 
(Salvisberg et al., 2014). The concordance rate between tear 
biomarkers versus cerebrospinal fluid (CSF) for Multiple Sclerosis 
is approximately 83% (Devos et al., 2001).
• Given the physiological dysregulation and clinical incidence which 
persist during spaceflight, including ocular and inflammatory 
alterations, we anticipate tear fluid biomarkers will have relevance 
for exploration class missions. 
Approach
• Tear collection is performed (‘TearFlow’ or similar, i.e. Schirmer
strip, microcapillary).  
1. Develop and validate tear collection, desiccation, 
reconstitution;  
2. Validate assessment of stress hormones, cytokines, viral 
DNA in reconstituted tears;
3. Stability study for desiccated tear samples;
4. ‘Normal range’ generation for relevant biomarkers in tears.   
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Project Objective 
• Compared to standard liquid collection, to assess both 
alterations due to stimulatory effect by the strips, or loss of 
protein due to binding on the strips.
• Current SANS (VIIP) measurements restricted to ‘form and 
function’, this technology would allow another dimension of eye 
assessment to inform crew of ocular alterations.
• Follow-on research may include assessment of clinical 
disease/clinical correlations, human space analog conditions, and 
astronauts prior to-, during-, and after- exposure to the 
spaceflight environment.
Strategic Alignment
This project aligns with HAT targets: Long Duration Space 
Medical Care, Long Duration Spaceflight Behavioral Health 
and Performance, Microgravity Biomedical Countermeasures 
for Long Duration Space flight and Microgravity Biomedical 
Countermeasures-Optimized Exercise.
Project Goal
• Pursue technology development to establish collection and assessment 
of tears to identify relevant biomarkers for spaceflight.  
Tear Biomarker 
Collection
3Pilot Study Development
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ID Task
Start 
Date
End 
Date 1 2 3 4 5 6 7 8 9 10 11 12
1 Project start date
2 Project kick off meeting
3 Identify and procure materials
4 Collect, process and analyze samples (materials
testing, assay development, stability study, etc.)
5 Data Analysis Visualization and clustering
6 Protocol Refinement & Report
7 Close out Project
Report
Profile
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Leveraging JSC Experience
• Dry chemistry and rehydration technology development (urine); 
• Dry saliva storage for cortisol (ISS astronauts); 
• Viral DNA detection by qPCR.
• Cytokine analysis and quantification
Month
• Cytokine analysis and quantification using a magnetic multiplex bead immunoassay (Milliplex, 
Merck Millipore, and UK) and the Luminex 200 system (Luminex Corp, USA)
Leveraging Glasgow Caledonian University, Scotland, UK Experience
• Non-human analogies, data mining – bioinformatics - visualization, and study design – non-human
Leveraging NIH - NAID Experience
Tear Collection Protocols
Validation and Stability
• Types of collection hardware
• Dried vs fresh sample
• Reconstitution options
• Biomarker stability to 1 year
Biomarkers
• Stress hormones - Cortisol, prolactin, ACTH (Immunoassay)
• Cytokines – Pro-, Anti-inflammatory, Th1/Th2/Th17 (Multiplex 
bead array)
• Latent Herpesvirus – HSV-1, VZV (Quantitative PCR)
Data Visualization, Clustering, 
Analysis & Mapping
Outcome 1
Marker 1
Marker 2
Marker 3
Marker 4
Marker 5
Outcome 2
Outcome 3
Left: Strip-based 
tear collection.  
Right:  Tear Fluid 
sampling using a 
glass 
microcapillary
(Microcap)
Source: Tear Fluid 
Biomarker Profiling: A 
Review of Multiplex 
Bead Analysis
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PCR for Latent Herpesviruses Multiplex analysis of cytokines
Technical Summary
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Relevance to Crew Health (SANS/VIIP)
SANS (VIIP)
Tear biomarkers analysis potentially opens a window to explore….
• Other dimensions of ocular health
• Conditions of the CNS
• Neurological state of human health
• Cause of SANS (VIIP) remains unknown.  We do not 
understand to whom or why SANS happens…  
• Biomarkers in saliva, plasma correlate well with 
dysregulated astronaut physiology (existing ISS data)
• Basal tears are a fluid directly related to ocular disease, 
CNS health and neurological diseases (Hagan et al, Zhou et 
al). 
• New innovative approach, no one has looked at Tear 
biomarkers to inform SANS (VIIP)
• Requires innovative technology development, validation 
(this proposal)
• Proposal will develop protocol to sample tears, enable dried 
long-term storage, reconstitution and assessing biomarker 
stability.    PI team has experience in dry chemistry.
• Selected biomarkers directly correlate with stress, 
inflammation, physiology which could impact SANS (VIIP)
• Developed protocols will ID biomarkers, provide 
technology to assess in astronauts/analogs, have stability for 
in-flight studies
• High likelihood of year one success
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